Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
19.53
-0.01 (-0.05%)
At close: Nov 2, 2026, 4:00 PM EST
19.53
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:29 PM EST
Odyssey Therapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Odyssey Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $35.33. The average 1-year stock price forecast is 80.90% higher than the current stock price, while the lowest is $27 (+38.25%) and the highest is $44 (+125.29%).
Price Target: $35.33 (+80.90%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Odyssey Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +104.81% | Oct 22, 2026 |
| UBS | UBS | Buy Maintains $27 | Buy | Maintains | $27 | +38.25% | Oct 21, 2026 |
| Raymond James | Raymond James | Buy Initiates $42 | Buy | Initiates | $42 | +115.05% | Oct 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $44 | Buy | Maintains | $44 | +125.29% | Sep 21, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
from 2.98M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-4.11
EPS Next Year
-4.36
from -4.11
EPS and Forward PE are based on non-GAAP adjusted numbers.